Identification of loci associated with risk of Parkinson’s disease adds to understanding of genetic factors contributing to development of the disease
Novel research has suggested the gut microbiome is involved in multiple sclerosis and could be a treatment target.
Data from a head-to-head, open-label study were presented at the 18th Congress of the International Headache Society in Vancouver (Canada, 7–10 September 2017).
This article examines physicochemical and cell-based assays and in vitro studies that have assessed the antioxidant properties of multitarget compounds.
In this review, the authors discuss the challenges associated with neural regeneration and review the progress of stem cell-based regenerative medicine.
Preliminary findings suggest that some cell therapies may be relatively safe and effective, but larger double-blinded placebo-controlled studies are needed to establish the long-term risks and benefits.